Effect of salivary stimulation therapies on salivary flow and chemotherapy-induced mucositis: A preliminary study

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Volumn 113, Issue 5, 2012, Pages 628-637

  Amaral, Tânia Mara Pimenta ^a   Campos, Camila Cláudia ^a   Dos Santos, Tálita Pollyanna Moreira ^a   Leles, Cláudio Rodrigues ^b   Teixeira, Antônio Lúcio ^a   Teixeira, Mauro Martins ^a   Bittencourt, Henrique ^a,c   Da Silva, Tarcília Aparecida ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862534060     PISSN: 22124403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oooo.2011.10.012     Document Type: Article

References (42)

1. Schmit-Pokorny K. Expanding indications for stem cell transplantation. Semin Oncol Nurs 2009;25:105-14.
2. Storb R. Preparative regimens for patients with leukemias and severe aplastic anemia (overview): biological basis, experimental animal studies and clinical trials at the Fred Hutchinson Cancer Research Center. Bone Marrow Transplant 1994;14(Suppl 4):S1-3.
3. Filicko J, Lazarus HM, Flomenberg N. Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment. Bone Marrow Transplant 2003;31:1-10. (Pubitemid 36181815)
4. Gabriel DA, Shea T, Olajida O, Serody JS, Comeau T. The effect of oral mucositis on morbidity and mortality in bone marrow transplant. Semin Oncol 2003;30:76-83. (Pubitemid 38120504)
5. Sonis ST. The pathobiology of mucositis. Nat Rev Cancer 2004;4:277-84. (Pubitemid 38525283)
6. Scully C, Sonis S, Diz PD. Oral mucositis. Oral Dis 2006;12:229-41. (Pubitemid 43736412)
7. Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral Oncol 2003; 39:91-100. (Pubitemid 36050914)
8. Fall-Dickson JM, Ramsay ES, Castro K, Woltz P, Sportés C. Oral mucositis-related oropharyngeal pain and correlative tumor necrosis factor-alpha expression in adult oncology patients undergoing hematopoietic stem cell transplantation. Clin Ther 2007;29(Suppl):2547-61. (Pubitemid 350299459)
9. Logan RM, Gibson RJ, Bowen JM, Stringer AM, Sonis ST, Keefe DM. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis. Cancer Chemother Pharmacol 2008;62:33-41. (Pubitemid 351537842)
10. Al-Dasooqi N, Gibson RJ, Bowen JM, Keefe DM. Matrix metalloproteinases: key regulators in the pathogenesis of chemotherapy- induced mucositis? Cancer Chemother Pharmacol 2009; 64:1-9.
11. Sonis ST, Costa JW Jr, Evitts SM, Lindquist LE, Nicolson M. Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy. Oral Surg Oral Med Oral Pathol 1992;74:749-55. (Pubitemid 23005444)
12. Epstein JB, Gorsky M, Guglietta A, Le N, Sonis ST. The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy. Cancer 2000;89:2258-65.
13. Dumbrigue HB, Sandow PL, Nguyen KH, Humphreys-Beher MG. Salivary epidermal growth factor levels decrease in patients receiving radiation therapy to the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:710-6.
14. McCarthy GM, Awde JD, Ghandi H, Vincent M, Kocha WI. Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncol 1998;34:484-90. (Pubitemid 28546862)
15. Jensen SB, Pedersen AM, Reibel J, Nauntofte B. Xerostomia and hypofunction of the salivary glands in cancer therapy. Support Care Cancer 2003;11:207-25. (Pubitemid 36723567)
16. Karolewska E, Konopka T, Pupek M, Chybicka A, Mendak M. Antibacterial potential of saliva in children with leukemia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:739-44.
17. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer 2010;18:1039-60.
18. Epstein JB, Tsang AH, Warkentin D, Ship JA. The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94:39-44. (Pubitemid 41151203)
19. Vissink A, Burlage FR, Spijkervet FK, Veerman EC, Nieuw Amerongen AV. Prevention and treatment of salivary gland hypofunction related to head and neck radiation therapy and chemotherapy. Support Cancer Ther 2004;1:111-8.
20. Gandemer V, Le Deley MC, Dollfus C, Auvrignon A, Bonnaure- Mallet M, Duval M, et al. Multicenter randomized trial of chewing gum for preventing oral mucositis in children receiving chemotherapy. Pediatr Hematol Oncol 2007;29:86-94. (Pubitemid 46213854)
21. Awidi A, Homsi U, Kakail RI, Mubarak A, Hassan A, Kelta M, et al. Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer. Eur J Cancer 2001; 37:2010-4. (Pubitemid 32938103)
22. Arora H, Pai KM, Maiya A, Vidyasagar MS, Rajeev A. Efficacy of He-Ne laser in the prevention and treatment of radiotherapyinduced oral mucositis in oral cancer patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:180-6.
23. Napeñas JJ, Brennan MT, Bahrani-Mougeot FK, Fox PC, Lockhart PB. Relationship between mucositis and changes in oral microflora during cancer chemotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:48-59. (Pubitemid 44909519)
24. Bonan PR, Kaminagakura E, Pires FR, Vargas PA, Almeida OP. Cytokeratin expression in initial oral mucositis of head and neck irradiated patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:205-11. (Pubitemid 43163222)
25. Loury D, Embree JR, Steinberg DA, Sonis ST, Fiddes JC. Effect of local application of the antimicrobial peptide IB-367 on the incidence and severity of oral mucositis in hamsters. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:544-51.
26. Bez C, Demarosi F, Sardella A, Lodi G, Bertolli VG, Annaloro C, et al. GM-CSF mouthrinses in the treatment of severe oral mucositis: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:311-5.
27. Epstein JB, Silverman S Jr, Paggiarino DA, Crockett S, Schubert MM, Senzer NN, et al. Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial. Cancer 2001;15:875-85. (Pubitemid 32783076)
28. Edgar WM. Sugar substitutes, chewing gum and dental caries: a review. Br Dent J 1998;184:29-32. (Pubitemid 128529476)
29. Nieuw Amerongen AV, Veerman EC. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 2003;11:226-31. (Pubitemid 36723568)
30. Amaral TMP, Rosa MA, Souza FTAD, Santos TPM, Silva MLV, Da Rosa P, et al. Salivary stimulation in patients with burning mouth syndrome. J Dent Res 2010;89(Spec Iss B):1048.
31. Hargitai IA, Sherman RG, Strother JM. The effects of electrostimulation on parotid saliva flow: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99:316-20. (Pubitemid 40260650)
32. Strietzel FP, Martín-Granizo R, Fedele S, Lo Russo L, Mignogna M, Reichart PA, et al. Electrostimulating device in the management of xerostomia. Oral Dis 2007;13:206-13.
33. World Health Organization. Handbook for reporting results of cancer treatment. Geneva: World Health Organization; 1979; 48:15-22.
34. Cheida AP. Hiperbolóide: instrumento de mastigação, um estimulador periomiofuncional. São Paulo: Ícone; 2004. p. 50-6.
35. Epstein JB, Schubert MM. Oral mucositis in myelosuppressive cancer therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:273-6.
36. Lockhart PB, Brennan MT, Kent ML, Packman CH, Norton HJ, Fox PC, et al. Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation. Bone Marrow Transplant 2005; 35:713-20. (Pubitemid 40520957)
37. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer- Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004;100:2026-46.
38. Holler E, Roncarolo MG, Hintermeier-Knabe R, Eissner G, Ertl B, Schulz U, et al. Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant 2000;25:237-41. (Pubitemid 30103011)
39. Berlanga-Acosta J, Gavilondo-Cowley J, López-Saura P, González-López T, Castro-Santana MD, López-Mola E, et al. Epidermal growth factor in clinical practice-a review of its biological actions, clinical indications and safety implications. Int Wound J 2009;6:331-46.
40. Ino M, Ushiro K, Ino C, Yamashita T, Kumazawa T. Kinetics of epidermal growth factor in saliva. Acta Otolaryngol Suppl 1993;500:126-30.
41. Girdler NM, McGurk M, Aqual S, Prince M. The effect of epidermal growth factor mouthwash on cytotoxic-induced oral ulceration: a phase I clinical trial. Am J Clin Oncol 1993; 18:403-6.
42. Thelin WR, Brennan MT, Lockhart PB, Singh ML, Fox PC, Papas AS, et al. The oral mucosa as a therapeutic target for xerostomia. Oral Dis 2008;14:683-9.